Agilent Technologies Inc.

NYSE:A   3:59:51 PM EDT
158.02
+1.08 (+0.69%)
4:00:00 PM EDT: $158.01 -0.01 (-0.01%)
Products

Agilent Receives FDA Companion Diagnostic Approval For Ki-67 IHC MIB-1 pharmDx

Published: 10/13/2021 22:16 GMT
Agilent Technologies Inc. (A) - Agilent Receives FDA Companion Diagnostic Approval for Ki-67 Ihc Mib-1 Pharmdx in High-risk Early Breast Cancer.